Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S
Fanjat, Y., Barazzutti, H., Di Mauro, I., Tabary-Martin, L., Duranton-Tanneur, V., Gimet, S., Bérard, H., Pedeutour, F.
Published in Cancer genetics (01.08.2021)
Published in Cancer genetics (01.08.2021)
Get full text
Journal Article
P-523 Multicentric phase II trial of cisplatin plus etoposidechemotherapy in advanced large-cell neuro endocrine carcinoma of the lung (LCNEC): Preliminary results. Study 03-02 from the “Groups Francais de Pneumo-cancerologie (GFPC)”
le Treut, J., Tabary-martin, L., Sault, M., Poirier, R., Chouaid, C., le Caer, H., Lena, H., Souquet, P., Monnet, I., Thomas, P.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2005)
Get full text
Journal Article